A very long consolidation in this range since 2014 when it IPO'd. This range is likely to continue unless there is a clear break out above the range and holds, a lot of Pharmas will consolidate for many years until they achieve approval for a breakthrough product and then it moves fast. If you are interested in this, you will need to research and see how far along their product cycles are through their approval phases.